According to market research study published by Gen Consulting Company, the market size of the global clinical trial supply & logistics sector is expected to rise by USD 1.2 billion with a CAGR of 6.2% by the end of 2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global clinical trial supply & logistics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the clinical trial supply & logistics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, phase, therapeutic area, end user, and region. The global market for clinical trial supply & logistics can be segmented by service: comparator sourcing, logistics & distribution, manufacturing, packaging, labeling, and blinding, storage & retention, others. Among these, the logistics & distribution segment was accounted for the highest revenue generator in 2021. Clinical trial supply & logistics market is further segmented by phase: phase I, phase II, phase III, phase IV. Based on therapeutic area, the clinical trial supply & logistics market is segmented into: cardiovascular diseases (CVDs), central nervous system (CNS) diseases, oncology, respiratory diseases, others. The CVDs segment held the largest share of the global clinical trial supply & logistics market in 2021 and is anticipated to hold its share during the forecast period. On the basis of end user, the clinical trial supply & logistics market also can be divided into: biologicals, medical devices, pharmaceuticals. In 2021, the pharmaceuticals segment made up the largest share of revenue generated by the clinical trial supply & logistics market. Clinical trial supply & logistics market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By service:
– comparator sourcing
– logistics & distribution
– manufacturing
– packaging, labeling, and blinding
– storage & retention
– others

By phase:
– phase I
– phase II
– phase III
– phase IV

By therapeutic area:
– cardiovascular diseases (CVDs)
– central nervous system (CNS) diseases
– oncology
– respiratory diseases
– others

By end user:
– biologicals
– medical devices
– pharmaceuticals

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report has also analysed the competitive landscape of the global clinical trial supply & logistics market with some of the key players being Almac Group Limited, Bilcare Limited, Catalent, Inc., Deutsche Post AG (DHL), Eurofins Scientific SE, Infosys Limited, KLIFO A/S, Lonza Group AG, Marken Limited (a UPS Company), Parexel International Corporation, PCI Pharma Services, The Piramal Group, Thermo Fisher Scientific, Inc., UDG Healthcare plc (now Inizio), Walden Pharma Group Services Ltd. (Movianto UK Limited), among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global clinical trial supply & logistics market.
– To classify and forecast the global clinical trial supply & logistics market based on service, phase, therapeutic area, end user, region.
– To identify drivers and challenges for the global clinical trial supply & logistics market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trial supply & logistics market.
– To identify and analyze the profile of leading players operating in the global clinical trial supply & logistics market.

Why Choose This Report
– Gain a reliable outlook of the global clinical trial supply & logistics market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.